Epi+Gen CHD™

Find Out Your Risk for a Heart Attack

 

Coronary heart disease is the most common type of┬áheart disease, and the major cause of heart attacks. Epi+Gen CHD™ is a patent-pending Next Generation test that assesses your near-term (3-year) risk for a heart attack. It is the first and only clinical test for coronary heart disease primary prevention that provides personalized insights based on two types of DNA biomarkers unique to you – genetic and epigenetic.

Why Epi+Gen CHD™

End-To-End Clinician Involvement

Epi+Gen CHD™ has to be ordered by a clinician. You can request the test from one of our telemedicine providers by filling out a simple, five-minute assessment to determine your eligibility for this test. Once the test report is ready, you can schedule a telemedicine consultation with the clinician to review your risk score.

Convenient and Private At-Home Test

Take the Epi+Gen CHD™ test in the comfort and privacy of your own home, whenever you want. After your request is approved by a clinician, simply collect your blood sample using the kit that we will mail to you, and send it back to us in a prepaid package. Once your sample is processed, your report is only shared with you and your prescribing clinician, and we are compliant with all applicable regulations, such as HIPAA.

More Than Just Genetics

Our evidence-based, patent-pending DNA test is not just another genetic test. In addition to your genetics, this DNA test also measures your epigenetic biomarkers which are very important because they are influenced by your environment and lifestyle. Together, your genetic and epigenetic biomarkers provide a more holistic estimate of your three-year risk for a heart attack.

Highly Sensitive Early Risk Evaluation

We analyze your unique DNA biomarker information through our proprietary Artificial Intelligence algorithms to determine, with high sensitivity, your likelihood of having a heart attack in the next 3 years. This risk estimate is reviewed by a clinician who will help tailor your personalized prevention plan.

Who should take Epi+Gen CHD™?

 

Our test is designed for those over the age of 35 who are interested in determining their risk for coronary heart disease. It is not appropriate for those who:

 

  • Are younger than 35.
  • Have already been diagnosed with coronary heart disease.
  • Have had a heart attack or any cardiac operation.
  • Have angina (pain, heaviness, or discomfort in your chest, arm, jaw or shoulder), especially with exertion.
  • Have had an abnormal cardiac stress test.

How it Works

1. Request Test Online

Fill out a simple eligibility questionnaire that will be reviewed by an elicity clinician, without the need for an office visit.

2. Collect and Send DNA Sample

Upon clinician approval, a step-by-step blood sample collection kit will be sent to your home. Send your sample to our CLIA lab using the prepaid return mailer included in your kit.

3. Report Generated

Once the test and analysis are complete, your risk score and prevention insights will be shared with the ordering clinician.

4. Discuss Your Results

Register with elicity to access your results, and discuss your results and prevention insights with the clinician who ordered your test.

Take Control Of Your Heart Health Today